In Silico Prediction, Characterization and Molecular Docking Studies on New Benzamide Derivatives
Recent research papers have confirmed the prevalence of microorganisms resistant to numerous antimicrobial agents, leading to spreading infections, extended hospitalizations, and increased mortality rates. The amplifying factors stimulate the need to discover new molecules able to cut off the developing resistance of pathogens against medicines. The current study presents a molecular docking procedure applied on 15 new pyridine–thiourea derivatives in order to test their activities against <i<S. aureus</i< and <i<E. coli</i<. The protein crystal structures were obtained from the Protein Data Bank (PDB). Processes such as geometry optimization, molecular properties (log P, polarizability, E HOMO, E LUMO, area and volume of the molecules, and ovality), drug-likeness, pharmacokinetic and pharmacogenomic profiles, and molecular docking studies are discussed in the present research. The approach involved the determination of the molecular properties for each chemical structure by using the Spartan 14 software, followed by the evaluation of their binding affinity through a specific docking score with the aid of the CLC Drug Discovery Workbench. Each studied compound established hydrogen bonds with the selected receptors, leading to suitable docking scores and increasing the chances of the compound being considered for further investigation..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
Processes - 11(2023), 479, p 479 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Roxana Roman [VerfasserIn] |
---|
Links: |
doi.org [kostenfrei] |
---|
Themen: |
Benzamide |
---|
doi: |
10.3390/pr11020479 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
DOAJ079990703 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ079990703 | ||
003 | DE-627 | ||
005 | 20230310174211.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230310s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/pr11020479 |2 doi | |
035 | |a (DE-627)DOAJ079990703 | ||
035 | |a (DE-599)DOAJ4460a03eeab841f4af75cca18317e984 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a TP1-1185 | |
050 | 0 | |a QD1-999 | |
100 | 0 | |a Roxana Roman |e verfasserin |4 aut | |
245 | 1 | 0 | |a In Silico Prediction, Characterization and Molecular Docking Studies on New Benzamide Derivatives |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Recent research papers have confirmed the prevalence of microorganisms resistant to numerous antimicrobial agents, leading to spreading infections, extended hospitalizations, and increased mortality rates. The amplifying factors stimulate the need to discover new molecules able to cut off the developing resistance of pathogens against medicines. The current study presents a molecular docking procedure applied on 15 new pyridine–thiourea derivatives in order to test their activities against <i<S. aureus</i< and <i<E. coli</i<. The protein crystal structures were obtained from the Protein Data Bank (PDB). Processes such as geometry optimization, molecular properties (log P, polarizability, E HOMO, E LUMO, area and volume of the molecules, and ovality), drug-likeness, pharmacokinetic and pharmacogenomic profiles, and molecular docking studies are discussed in the present research. The approach involved the determination of the molecular properties for each chemical structure by using the Spartan 14 software, followed by the evaluation of their binding affinity through a specific docking score with the aid of the CLC Drug Discovery Workbench. Each studied compound established hydrogen bonds with the selected receptors, leading to suitable docking scores and increasing the chances of the compound being considered for further investigation. | ||
650 | 4 | |a benzamide | |
650 | 4 | |a molecular docking studies | |
650 | 4 | |a thiourea | |
650 | 4 | |a QSAR | |
650 | 4 | |a pyridine | |
653 | 0 | |a Chemical technology | |
653 | 0 | |a Chemistry | |
700 | 0 | |a Lucia Pintilie |e verfasserin |4 aut | |
700 | 0 | |a Diana Nuță |e verfasserin |4 aut | |
700 | 0 | |a Speranța Avram |e verfasserin |4 aut | |
700 | 0 | |a Catalin Buiu |e verfasserin |4 aut | |
700 | 0 | |a Catalina Sogor |e verfasserin |4 aut | |
700 | 0 | |a Carmen Limban |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Processes |d MDPI AG, 2013 |g 11(2023), 479, p 479 |w (DE-627)DOAJ000006696 |x 22279717 |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2023 |g number:479, p 479 |
856 | 4 | 0 | |u https://doi.org/10.3390/pr11020479 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/4460a03eeab841f4af75cca18317e984 |z kostenfrei |
856 | 4 | 0 | |u https://www.mdpi.com/2227-9717/11/2/479 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2227-9717 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
951 | |a AR | ||
952 | |d 11 |j 2023 |e 479, p 479 |